Signaling Pathways
-
B2240 OlanzapineTarget: 5-HT2 Receptors|D2 ReceptorsSummary: Antagonist of 5-HT2A and dopamine D2 receptors
-
B1407 Dabrafenib (GSK2118436)3 CitationTarget: RafSummary: Inhibitor of BRAF(V600) mutants
-
B1267 RefametinibTarget: MEKSummary: MEK 1/ MEK 2 inhibitor
-
B1114 T 705Target: RNA PolymerasesSummary: Potent and selective RNA-dependent RNA polymerase inhibitor
-
B1175 PalovaroteneTarget: RARsSummary: Selective retinoic acid receptor gamma(RAR-γ) agonist
-
B2210 AzilsartanTarget: Angiotensin AT1 ReceptorsSummary: Potent angiotensin II type 1 (AT1) receptor inverse agonist
-
B1111 N6022Target: S-nitrosoglutathione reductaseSummary: GSNOR inhibitor
-
B1051 GSK 6503942 CitationTarget: SGKSummary: SGK1 inhibitor
-
B1255 AZ505Target: SMYD2Summary: SMYD2 inhibitor,potent and selective
-
B2186 GSK2636771Target: PI3KSummary: PIK3 inhibitor